# 1 Total

**Page range:** 54â€“54

```text
1
Total
203
3
8
47
12
38
Of the 214 events for which therapy with pralsetinib was interrupted, discontinued or
dose reduced, 164 had resolved, 28 had resolved with sequelae and 3 were resolving.
Of these 214 events, corrective treatment was received for 191 events, thus confounding
the dechallenge information. Treatment included broad-spectrum antibiotics, antivirals,
steroids, symptomatic management and corrective surgery.
```